// App-Quantinova.ai

PB2125 : Empowering Cancer Patients for Non-Pharmacological Primary Prevention and Early Recognition of Cancer-Associated Thrombosis (CAT): The EMPATIC-CP Survey

Researchers

Presenter

  • M. Merino

Principal Investigators

  • E. Colom

  • F. Esposito

  • C. Beato

  • A. Arajo

  • Y. De Miguel

  • C. Font

Medical Centers

  • Pharmamar, Barcelona, Spain

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Hospital Universitario Virgen del Rocio, Sevilla, Spain

  • Centro Hospitalar do Porto, Porto, Portugal

Locations

  • Spain

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Catalase

Drug/Treatment

  • Empatic

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A